Jeffrey S. Kahn

4.4k total citations
50 papers, 3.2k citations indexed

About

Jeffrey S. Kahn is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Jeffrey S. Kahn has authored 50 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Epidemiology, 29 papers in Infectious Diseases and 9 papers in Surgery. Recurrent topics in Jeffrey S. Kahn's work include Respiratory viral infections research (31 papers), Viral gastroenteritis research and epidemiology (10 papers) and Parvovirus B19 Infection Studies (10 papers). Jeffrey S. Kahn is often cited by papers focused on Respiratory viral infections research (31 papers), Viral gastroenteritis research and epidemiology (10 papers) and Parvovirus B19 Infection Studies (10 papers). Jeffrey S. Kahn collaborates with scholars based in United States, France and Belgium. Jeffrey S. Kahn's co-authors include Carla Weibel, Kenneth McIntosh, Frank Esper, Marie L. Landry, David Ferguson, Richard A. Martinello, Eugene D. Shapiro, Marietta Vázquez, Linda Buonocore and Deniz Kesebir and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Jeffrey S. Kahn

50 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey S. Kahn United States 27 2.0k 1.7k 694 490 243 50 3.2k
Francisco Pozo Spain 33 2.6k 1.3× 1.2k 0.7× 606 0.9× 284 0.6× 237 1.0× 148 3.3k
Astrid Vabret France 42 3.3k 1.6× 3.2k 1.8× 863 1.2× 334 0.7× 249 1.0× 193 5.4k
Inmaculada Casas Spain 37 3.4k 1.7× 1.9k 1.1× 931 1.3× 401 0.8× 284 1.2× 153 4.5k
F. Freymuth∘ France 40 4.0k 2.0× 2.9k 1.6× 906 1.3× 368 0.8× 258 1.1× 206 5.6k
Frank Esper United States 20 1.1k 0.6× 1.3k 0.7× 385 0.6× 341 0.7× 74 0.3× 39 2.0k
Marilda Mendonça Siqueira Brazil 31 2.0k 1.0× 1.4k 0.8× 302 0.4× 147 0.3× 308 1.3× 183 3.3k
Ortwin Adams Germany 33 1.3k 0.7× 1.5k 0.8× 231 0.3× 163 0.3× 330 1.4× 125 3.7k
Helen Y. Chu United States 31 1.5k 0.8× 3.2k 1.8× 468 0.7× 192 0.4× 725 3.0× 146 5.0k
Francesca Rovida Italy 27 1.2k 0.6× 1.6k 0.9× 240 0.3× 304 0.6× 154 0.6× 74 2.6k
Yae‐Jean Kim South Korea 26 875 0.4× 1.6k 0.9× 336 0.5× 462 0.9× 153 0.6× 151 3.0k

Countries citing papers authored by Jeffrey S. Kahn

Since Specialization
Citations

This map shows the geographic impact of Jeffrey S. Kahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey S. Kahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey S. Kahn more than expected).

Fields of papers citing papers by Jeffrey S. Kahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey S. Kahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey S. Kahn. The network helps show where Jeffrey S. Kahn may publish in the future.

Co-authorship network of co-authors of Jeffrey S. Kahn

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey S. Kahn. A scholar is included among the top collaborators of Jeffrey S. Kahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey S. Kahn. Jeffrey S. Kahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Messiah, Sarah, et al.. (2023). Persistent symptoms and conditions among children and adolescents hospitalised with COVID-19 illness: a qualitative study. BMJ Open. 13(9). e069073–e069073. 3 indexed citations
2.
Ye, Haihang, Abdullah Bayram, Tingting Zhang, et al.. (2022). Gold Nanourchins Improve Virus Targeting and Plasmonic Coupling for Virus Diagnosis on a Smartphone Platform. ACS Sensors. 7(12). 3741–3752. 8 indexed citations
3.
Xie, Luyu, et al.. (2022). Long-term physical, mental and social health effects of COVID-19 in the pediatric population: a scoping review. World Journal of Pediatrics. 18(3). 149–159. 23 indexed citations
4.
Messiah, Sarah, Luyu Xie, M. Sunil Mathew, et al.. (2021). Results of COVID-19 Surveillance in a Large United States Pediatric Healthcare System over One Year. Children. 8(9). 752–752. 9 indexed citations
5.
Huynh, HoangDinh, Ruth Levitz, Rong Huang, & Jeffrey S. Kahn. (2021). mTOR kinase is a therapeutic target for respiratory syncytial virus and coronaviruses. Scientific Reports. 11(1). 24442–24442. 6 indexed citations
6.
Levitz, Ruth, Yajing Gao, Igor Dozmorov, et al.. (2017). Distinct patterns of innate immune activation by clinical isolates of respiratory syncytial virus. PLoS ONE. 12(9). e0184318–e0184318. 18 indexed citations
7.
Miller, Michael A., Carla Weibel, Jeffrey S. Kahn, & Warren A. Andiman. (2011). Seroepidemiology of WU polyomavirus among children exposed perinatally to HIV‐1. Journal of Medical Virology. 84(2). 188–193. 8 indexed citations
8.
Weibel, Carla, et al.. (2009). WU Polyomavirus in Patients Infected with HIV or Hepatitis C Virus, Connecticut, USA, 2007. Emerging infectious diseases. 15(7). 1095–1097. 12 indexed citations
9.
Kahn, Jeffrey S., Deniz Kesebir, Susan F. Cotmore, et al.. (2008). Seroepidemiology of Human Bocavirus Defined Using Recombinant Virus-Like Particles. The Journal of Infectious Diseases. 198(1). 41–50. 82 indexed citations
10.
Guo, Xiaojie, et al.. (2007). Seroepidemiology of group I human coronaviruses in children. Journal of Clinical Virology. 40(3). 207–213. 45 indexed citations
11.
Kesebir, Deniz, Marietta Vázquez, Carla Weibel, et al.. (2006). Human Bocavirus Infection in Young Children in the United States: Molecular Epidemiological Profile and Clinical Characteristics of a Newly Emerging Respiratory Virus. The Journal of Infectious Diseases. 194(9). 1276–1282. 249 indexed citations
12.
Kahn, Jeffrey S.. (2006). The widening scope of coronaviruses. Current Opinion in Pediatrics. 18(1). 42–47. 28 indexed citations
13.
Esper, Frank, Eugene D. Shapiro, Marie L. Landry, & Jeffrey S. Kahn. (2005). Reply to van der Hoek and Berkhout, Ebihara et al., and Belay et al.. The Journal of Infectious Diseases. 192(2). 353–353. 1 indexed citations
14.
Kahn, Jeffrey S. & Kenneth McIntosh. (2005). History and Recent Advances in Coronavirus Discovery. The Pediatric Infectious Disease Journal. 24(11). S223–S227. 419 indexed citations
15.
Esper, Frank, Eugene D. Shapiro, Carla Weibel, et al.. (2005). Association between a Novel Human Coronavirus and Kawasaki Disease. The Journal of Infectious Diseases. 191(4). 499–502. 272 indexed citations
16.
Kahn, Jeffrey S.. (2003). Human metapneumovirus: a newly emerging respiratory pathogen. Current Opinion in Infectious Diseases. 16(3). 255–258. 52 indexed citations
17.
Kahn, Jeffrey S.. (2003). Human metapneumovirus, a newly emerging respiratory virus. The Pediatric Infectious Disease Journal. 22(10). 923–924. 15 indexed citations
18.
Martinello, Richard A., et al.. (2002). Correlation between Respiratory Syncytial Virus Genotype and Severity of Illness. The Journal of Infectious Diseases. 186(6). 839–842. 132 indexed citations
19.
Kahn, Jeffrey S.. (2000). Respiratory syncytial virus vaccine development. Current Opinion in Pediatrics. 12(3). 257–262. 9 indexed citations
20.
McCarthy, Paul L., Jeffrey S. Kahn, Eugene D. Shapiro, & Jean E. Klig. (1998). Fever without apparent source on clinical examination, Infectious diseases, and Lower respiratory infections in children. Current Opinion in Pediatrics. 10(1). 101–116. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francisco Pozo Breakdown of academic impact, for papers by Astrid Vabret Breakdown of academic impact, for papers by Inmaculada Casas Breakdown of academic impact, for papers by F. Freymuth∘ Breakdown of academic impact, for papers by Frank Esper Breakdown of academic impact, for papers by Marilda Mendonça Siqueira Breakdown of academic impact, for papers by Ortwin Adams Breakdown of academic impact, for papers by Helen Y. Chu Breakdown of academic impact, for papers by Francesca Rovida Breakdown of academic impact, for papers by Yae‐Jean Kim
Rankless by CCL
2026